Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

ROCKET DOCTOR AI INC. ANNOUNCES UPSIZE ON LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. upsized its non‑brokered private placement of units to a maximum of $5.2 million in gross proceeds.
  • Each unit is priced at $0.70, and all other terms of the offering remain unchanged from the prior announcements on Jan 9 2025 and Jan 16 2026.
  • The company filed an amended and restated offering document reflecting the increased size; proceeds are intended to fund ongoing operations and growth initiatives.

Key Details

  • Upsized Offering Size: Increased to a maximum of $5.2 million in gross proceeds.
  • Unit Price: $0.70 per unit (unchanged).
  • Units Offered: Non‑brokered private placement units (the “Units”).
  • Previous Announcements: Original private placement announced on January 9, 2025 and January 16, 2026.
  • Terms: All other terms of the offering remain unchanged from the prior disclosures.
  • Documentation: Amended and restated offering document filed and available via the company’s SEDAR profile (www.sedarplus.ca) and corporate website (www.rocketdoctor.ai).
  • Use of Proceeds: Not detailed in this release; referenced as “use of proceeds” in forward‑looking statements.
  • Regulatory Notices: The press release does not constitute an offer or solicitation in the United States; securities are not registered under the U.S. 1933 Act.

Notable Quotes

  • “We are pleased to announce this upsized private placement, reflecting strong investor demand and providing us with additional capital to accelerate our AI‑driven healthcare initiatives,” – Dr. Essam Hamza, CEO.
Read the original news release →

More from Rocket Doctor AI Inc.